← Every applicant
Novast Labs FDA Approvals
9 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| DROSPIRENONE AND ESTRADIOLNew drugOct 28, 2025TABLET, ORAL |
| CONJUGATED ESTROGENSNew drugOct 15, 2025TABLET, ORAL |
| CONJUGATED ESTROGENSNew drugOct 15, 2025TABLET, ORAL |
| DILTIAZEM HYDROCHLORIDENew drugJul 2, 2025CAPSULE, EXTENDED RELEASE, ORAL |
| CYCLOBENZAPRINE HYDROCHLORIDENew drugAug 27, 2024CAPSULE, EXTENDED RELEASE, ORAL |
| MESALAMINENew drugAug 22, 2024CAPSULE, EXTENDED RELEASE, ORAL |
| RANOLAZINENew drugSep 27, 2023TABLET, EXTENDED RELEASE, ORAL |
| TRI-LO-LINYAHNew drugSep 2, 2022TABLET, ORAL |
| PRAMIPEXOLE DIHYDROCHLORIDENew drugFeb 3, 2022TABLET, EXTENDED RELEASE, ORAL |